Evidence map›Paper›PMID 40496877›Full record

ReviewEClinicalMedicine2025

European advances in digital rheumatology: explainable insights and personalized digital health tools for psoriatic arthritis.

Leontios J Hadjileontiadis, Vasileios Charisis, Stelios Hadjidimitriou, Sofia B Dias, George Apostolidis, Giannis Dimaridis, Ilias Kitsas, Angelos Karlas, Nikolina-Alexia Fasoula, Francesca Levi-Schaffer and 7 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Leontios J HadjileontiadisDepartment of Biomedical Engineering & Biotechnology, College of Medicine and Life Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
Vasileios CharisisDepartment of Electrical & Computer Engineering, College of Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Stelios HadjidimitriouDepartment of Electrical & Computer Engineering, College of Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Sofia B DiasCentro Interdisciplinar de Performance Humana (CIPER), Faculdade de Motricidade Humana, Universidade de Lisboa, Lisbon, Portugal.
George ApostolidisDepartment of Electrical & Computer Engineering, College of Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Giannis DimaridisDepartment of Electrical & Computer Engineering, College of Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Ilias KitsasDepartment of Electrical & Computer Engineering, College of Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Angelos KarlasClinic and Polyclinic for Vascular and Endovascular Surgery, TUM University Hospital, Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
Nikolina-Alexia FasoulaClinic and Polyclinic for Vascular and Endovascular Surgery, TUM University Hospital, Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
Francesca Levi-SchafferInstitute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Hugo SilvaInstituto de Telecomunicações (IT), Instituto Superior Técnico (IST), Universidade de Lisboa, Lisbon, Portugal.
Theodoros Dimitroulas4th Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Ana Maria RodriguesComprehensive Health Research Centre (CHRC), Nova Medical School and Rheumatology, Faculdade de Ciências Médicas, Universidade de Lisboa, Lisbon, Portugal.
Laura C CoatesNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Jolanda LuimeDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Ilja TchetverikovDepartment of Rheumatology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
iPROLEPSIS consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The shift from traditional to technology-based diagnosis and management of psoriatic arthritis (PsA) represents a significant evolution in patient care. Traditionally, PsA was diagnosed and managed through clinical evaluations, physical examinations, and basic imaging techniques. With the evolution of digital technologies, the PsA care is transforming, giving rise to the field of digital rheumatology. In this vein, Europe has invested in research initiatives, like iPROLEPSIS, that could accelerate this transformation and redefine PsA care within a digital world. In this

Indexed as

Digital rheumatologyDigital therapeuticsExplainable AI modelsiPROLEPSIS European research initiativeNovel digital biomarkersPsoriatic arthritis

Identifiers

PMID40496877
PMCPMC12146546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.